Does Vitamin D Prophylaxsis in Pregnancy Decrease the Risk of Adverse Neonatal Outcomes?
ACOG ePoster. Persad M. 04/27/18; 211672; 33N
Malini Persad
Malini Persad
Login now to access Regular content available to all registered users.

You may also access this content "anytime, anywhere" with the Free MULTILEARNING App for iOS and Android
Abstract
Discussion Forum (0)
Rate & Comment (0)
Introduction: Maternal vitamin D deficiency has been associated with adverse neonatal outcomes including preterm birth, immunosuppression, infection, low birth weight, neonatal seizures, asthma and fractures. We set out to determine if antepartum vitamin D prophylaxis decreases the risk of adverse neonatal outcomes.

Methods: A prospective cohort study was performed at a university hospital between October 2016 to July 2017. Included in the study were women with a confirmed intrauterine pregnancy, between 12-16 weeks gestation. Excluded from the study were women taking vitamin D supplements prior to enrollment, diagnosed with a malabsorption disorder, or carrying a fetus with a known anomaly. Women were assigned to receive vitamin D 3000IU daily or no supplement in addition to prenatal vitamins. Participants were routinely assessed for medication compliance. Neonatal factors were collected and compared between those who were compliant and those who were not. Adverse neonatal events were defined as preterm birth, Apgar score
Introduction: Maternal vitamin D deficiency has been associated with adverse neonatal outcomes including preterm birth, immunosuppression, infection, low birth weight, neonatal seizures, asthma and fractures. We set out to determine if antepartum vitamin D prophylaxis decreases the risk of adverse neonatal outcomes.

Methods: A prospective cohort study was performed at a university hospital between October 2016 to July 2017. Included in the study were women with a confirmed intrauterine pregnancy, between 12-16 weeks gestation. Excluded from the study were women taking vitamin D supplements prior to enrollment, diagnosed with a malabsorption disorder, or carrying a fetus with a known anomaly. Women were assigned to receive vitamin D 3000IU daily or no supplement in addition to prenatal vitamins. Participants were routinely assessed for medication compliance. Neonatal factors were collected and compared between those who were compliant and those who were not. Adverse neonatal events were defined as preterm birth, Apgar score
Code of conduct/disclaimer available in General Terms & Conditions

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies